BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 31220085)

  • 21. Analysis of serious adverse events in a pediatric community-acquired pneumonia randomized clinical trial in Malawi.
    Ginsburg AS; May S
    Sci Rep; 2022 Mar; 12(1):3538. PubMed ID: 35241775
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Malawian children with fast-breathing pneumonia with and without comorbidities.
    Ginsburg AS; Mvalo T; Hwang J; Phiri M; McCollum ED; Maliwichi M; Schmicker R; Phiri A; Lufesi N; May S
    Pneumonia (Nathan); 2021 Feb; 13(1):3. PubMed ID: 33627192
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Should fast breathing pneumonia cases be treated with antibiotics? The scientific rationale for revisiting management in Low and Middle income countries.
    Jehan F; Nisar I; Kerai S; Brown N; Ambler G; Zaidi AKM
    Int J Infect Dis; 2019 Aug; 85():64-66. PubMed ID: 31176034
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Determining the quality of IMCI pneumonia care in Malawian children.
    Bjornstad E; Preidis GA; Lufesi N; Olson D; Kamthunzi P; Hosseinipour MC; McCollum ED
    Paediatr Int Child Health; 2014 Feb; 34(1):29-36. PubMed ID: 24091151
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identifying modifiable risk factors for mortality in children aged 1-59 months admitted with WHO-defined severe pneumonia: a single-centre observational cohort study from rural Malawi.
    Eckerle M; Mvalo T; Smith AG; Kondowe D; Makonokaya D; Vaidya D; Hosseinipour MC; McCollum ED
    BMJ Paediatr Open; 2022 Apr; 6(1):. PubMed ID: 36053605
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A randomized controlled trial of zinc as adjuvant therapy for severe pneumonia in young children.
    Basnet S; Shrestha PS; Sharma A; Mathisen M; Prasai R; Bhandari N; Adhikari RK; Sommerfelt H; Valentiner-Branth P; Strand TA;
    Pediatrics; 2012 Apr; 129(4):701-8. PubMed ID: 22392179
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A randomized controlled trial of the effect of zinc as adjuvant therapy in children 2-35 mo of age with severe or nonsevere pneumonia in Bhaktapur, Nepal.
    Valentiner-Branth P; Shrestha PS; Chandyo RK; Mathisen M; Basnet S; Bhandari N; Adhikari RK; Sommerfelt H; Strand TA
    Am J Clin Nutr; 2010 Jun; 91(6):1667-74. PubMed ID: 20375190
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vitamin A supplements ameliorate the adverse effect of HIV-1, malaria, and diarrheal infections on child growth.
    Villamor E; Mbise R; Spiegelman D; Hertzmark E; Fataki M; Peterson KE; Ndossi G; Fawzi WW
    Pediatrics; 2002 Jan; 109(1):E6. PubMed ID: 11773574
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of HIV-1 status on the radiological presentation and clinical outcome of children with WHO defined community-acquired severe pneumonia.
    Jeena PM; Minkara AK; Corr P; Bassa F; McNally LM; Coovadia HM; Fox M; Hamer DH; Thea D
    Arch Dis Child; 2007 Nov; 92(11):976-9. PubMed ID: 17595201
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Predicting Hospitalised Paediatric Pneumonia Mortality Risk: An External Validation of RISC and mRISC, and Local Tool Development (RISC-Malawi) from Malawi.
    Hooli S; Colbourn T; Lufesi N; Costello A; Nambiar B; Thammasitboon S; Makwenda C; Mwansambo C; McCollum ED; King C
    PLoS One; 2016; 11(12):e0168126. PubMed ID: 28030608
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quality of Case Management for Pneumonia and Diarrhea Among Children Seen at Health Facilities in Southern Malawi.
    Kobayashi M; Mwandama D; Nsona H; Namuyinga RJ; Shah MP; Bauleni A; Vanden Eng J; Rowe AK; Mathanga DP; Steinhardt LC
    Am J Trop Med Hyg; 2017 May; 96(5):1107-1116. PubMed ID: 28500813
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of age, polymicrobial disease, and maternal HIV status on treatment response and cause of severe pneumonia in South African children: a prospective descriptive study.
    McNally LM; Jeena PM; Gajee K; Thula SA; Sturm AW; Cassol S; Tomkins AM; Coovadia HM; Goldblatt D
    Lancet; 2007 Apr; 369(9571):1440-1451. PubMed ID: 17467514
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bubble continuous positive airway pressure for children with high-risk conditions and severe pneumonia in Malawi: an open label, randomised, controlled trial.
    McCollum ED; Mvalo T; Eckerle M; Smith AG; Kondowe D; Makonokaya D; Vaidya D; Billioux V; Chalira A; Lufesi N; Mofolo I; Hosseinipour M
    Lancet Respir Med; 2019 Nov; 7(11):964-974. PubMed ID: 31562059
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Failure of standard antimicrobial therapy in children aged 3-59 months with mild or asymptomatic HIV infection and severe pneumonia.
    Jeena P; Thea DM; MacLeod WB; Chisaka N; Fox MP; Coovadia HM; Qazi S;
    Bull World Health Organ; 2006 Apr; 84(4):269-75. PubMed ID: 16628299
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Integrated paediatric fever management and antibiotic over-treatment in Malawi health facilities: data mining a national facility census.
    Johansson EW; Selling KE; Nsona H; Mappin B; Gething PW; Petzold M; Peterson SS; Hildenwall H
    Malar J; 2016 Aug; 15(1):396. PubMed ID: 27488343
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Can child pneumonia in low-resource settings be treated without antibiotics? A systematic review & meta-analysis.
    Walker PJ; Wilkes C; Duke T; Graham HR;
    J Glob Health; 2022 Nov; 12():10007. PubMed ID: 36370376
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interventions to reduce Staphylococcus aureus in the management of eczema.
    George SM; Karanovic S; Harrison DA; Rani A; Birnie AJ; Bath-Hextall FJ; Ravenscroft JC; Williams HC
    Cochrane Database Syst Rev; 2019 Oct; 2019(10):. PubMed ID: 31684694
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Resveratrol improves efficacy of oral amoxicillin against childhood fast breathing pneumonia in a randomized placebo-controlled double blind clinical trial.
    Qiang L; Di Y; Jiang Z; Xu J
    Microb Pathog; 2018 Jan; 114():209-212. PubMed ID: 29198820
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Can WHO therapy failure criteria for non-severe pneumonia be improved in children aged 2-59 months?
    Hazir T; Qazi SA; Nisar YB; Maqbool S; Asghar R; Iqbal I; Khalid S; Randhawa S; Aslam S; Riaz S; Abbasi S
    Int J Tuberc Lung Dis; 2006 Aug; 10(8):924-31. PubMed ID: 16898379
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A prospective validation study in South-West Nigeria on caregiver report of childhood pneumonia and antibiotic treatment using Demographic and Health Survey (DHS) and Multiple Indicator Cluster Survey (MICS) questions.
    Ayede AI; Kirolos A; Fowobaje KR; Williams LJ; Bakare AA; Oyewole OB; Olorunfemi OB; Kuna O; Iwuala NT; Oguntoye A; Kusoro SO; Okunlola ME; Qazi SA; Nair H; Falade AG; Campbell H
    J Glob Health; 2018 Dec; 8(2):020806. PubMed ID: 30254744
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.